Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7414132 Opioid receptor antagonists

Patent 7414132 was granted and assigned to Eli Lilly and Company on August, 2008 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Charles Howard Mitch0

Concepcion Pedregal-Tercero0

Marta Garcia De La Torre0

Nuria Diaz Buezo0

Prabhakar Kondaji Jadhav0

Date of Patent

August 19, 2008

0

Patent Application Number

105811780

Date Filed

December 15, 2004

0

Patent Citations Received

US Patent 11998525 Compositions and methods for the treatment of depression

0

US Patent 11998524 Forms of aticaprant

0

Patent Primary Examiner

James O. Wilson

0

Patent abstract

A compound of the formula (I); wherein the variables X1 to X10, R1 to R7 including R3′, E, W, v, y, z, A and B are as described, or a pharmaceutically acceptable salt, solvate, enantiomer, racemate, diastereomer or mixtures thereof, useful for the treatment, prevention or amelioration of obesity and Related Diseases is disclosed.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7414132 Opioid receptor antagonists

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.